By integrating omics profiling with machine learning-driven biomarker discovery, we uncover a mechanistic hierarchy wherein ATP6AP1-mediated lysosomal acidification fuels a self-reinforcing cycle of immune evasion, offering actionable insights for overcoming immunotherapy resistance in HCC. This evidence concerns the gene ATP6AP1 and hepatocellular carcinoma.